Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Human Polyclonal ALS2 Primary Antibody for ICC, IF - ABIN257842
Çobanoğlu, Ozansoy, Başak: Are alsin and spartin novel interaction partners? in Biochemical and biophysical research communications 2012
Show all 2 Pubmed References
We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 (show SPG11 Antibodies) in three families and TFG/SPG57, SACS and ALS2 in one family each). A heterozygous mutation in a gene involved in an autosomal dominant HSP (ATL1/SPG3A (show ATL1 Antibodies)) was also identified in one additional family
This study identified two novel ALS2 mutations in two Pakistani families with infantile-onset ascending hereditary spastic paraplegia cosegregating with the disease.
novel compound heterozygous ALS2 deletion mutations were identified in two siblings with infantile ascending hereditary spastic paraplegia.
We identified a novel homozygous splice-site mutation (c.3512+1G>A) in the ALS2 gene (NM_020919.3) encoding alsin that segregated with the disease in this family
Data indicate a splice-site mutation of the amyotrophic lateral sclerosis 2 (juvenile) protein (ALS2) in four children of a consanguineous family with infantile-onset ascending hereditary spastic paraplegia.
The ALS2 gene should be screened for mutations in patients who present with generalized dystonia and cerebellar signs.
The ALS2 mutation c.2761C>T leading to infantile-onset hereditary spastic paraplegia resides in the pleckstrin (show PLEK Antibodies) domain, which is involved in the overall neuronal development or maintenance.
ALS2 sequencing revealed two heterozygous mutations: the missense variant c.299 G>T, leading to the replacement of a serine with an isoleucine (p.S100I), and the splicing variant c.2580-2 A>G in brothers with juvenile amyotrophic lateral sclerosis.
these results suggest that Als2 is a binding partner of Uxt (show UXT Antibodies) and Als2/Uxt (show UXT Antibodies) interaction could be important for the activation of Nf-kappaB (show NFKB1 Antibodies) pathway.
Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene.
two ALS-linked factors, SQSTM1 (show SQSTM1 Antibodies) and ALS2, have distinct but additive protective roles against mutant SOD1 (show SOD1 Antibodies)-mediated toxicity by modulating neuronal proteostasis possibly through the autophagy-endolysosomal system.
alsin and spartin (show SPG20 Antibodies) may interact each other physically.
Alsin and SOD1 (show SOD1 Antibodies)(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity.
Rab5 (show RAB5A Antibodies)-mediated endocytosis was severely altered in ALS2(-/-) neurons.
ALS2/Alsin exacerbates motor dysfunction in a SOD1 (show SOD1 Antibodies)-expressing mouse ALS model by disturbing endolysosomal trafficking
Als2(-/-) mice showed a significantly lower spontaneous rearing activity than wild-type litters. These genetic background- and/or gender-specific findings suggest the presence of modifiers for life span and motor activities in Als2(-/-) mice.
Alsin is a Rab5 (show RAB5A Antibodies) and Rac1 guanine nucleotide exchange factor (show ARHGEF12 Antibodies)
Rac1, PI3 kinase (show PIK3CA Antibodies), and Akt3 (show AKT3 Antibodies) have roles in an anti-apoptotic pathway triggered by ALS2 that antagonizes SOD1 (show SOD1 Antibodies) mutant-induced motoneuronal cell death
loss of ALS2 function is not sufficient to cause motor neuron disease in a mouse model. However, lack of ALS2 did predispose neurons to oxidative stress, implying that ALS2 might serve as a risk factor for motor neuron disease.
The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene.
, amyotrophic lateral sclerosis 2 (juvenile)
, amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein
, amyotrophic lateral sclerosis 2 protein
, amyotrophic lateral sclerosis 2 protein homolog
, amyotrophic lateral sclerosis protein 2 homolog
, amyotrophic lateral sclerosis 2 (juvenile) homolog